Involvement of the "I" domain of LFA-1 in selective binding to ligands ICAM-1 and ICAM-3.
about
cDNA cloning and chromosomal localization of the human telencephalin and its distinctive interaction with lymphocyte function-associated antigen-1Crystal structure of the I-domain from the CD11a/CD18 (LFA-1, alpha L beta 2) integrinThe structure of the two amino-terminal domains of human ICAM-1 suggests how it functions as a rhinovirus receptor and as an LFA-1 integrin ligandA binding interface on the I domain of lymphocyte function-associated antigen-1 (LFA-1) required for specific interaction with intercellular adhesion molecule 1 (ICAM-1)Structural study of N-linked oligosaccharides of human intercellular adhesion molecule-3 (CD50).Characteristics of cation binding to the I domains of LFA-1 and MAC-1. The LFA-1 I domain contains a Ca2+-binding site.An atomic resolution view of ICAM recognition in a complex between the binding domains of ICAM-3 and integrin alphaLbeta2.Micromechanical tests of adhesion dynamics between neutrophils and immobilized ICAM-1Analysis of the binding site on intercellular adhesion molecule 3 for the leukocyte integrin lymphocyte function-associated antigen 1.Leukocyte adhesion--structure and function of human leukocyte beta2-integrins and their cellular ligands.Utilization of I-domain of LFA-1 to Target Drug and Marker Molecules to Leukocytes.Two functional states of the CD11b A-domain: correlations with key features of two Mn2+-complexed crystal structures.ICAMs redistributed by chemokines to cellular uropods as a mechanism for recruitment of T lymphocytes.Aggregatibacter actinomycetemcomitans leukotoxin requires beta-sheets 1 and 2 of the human CD11a beta-propeller for cytotoxicity.Targeting platelet-leukocyte interactions: identification of the integrin Mac-1 binding site for the platelet counter receptor glycoprotein Ibalpha.Fibrinogen decreases cardiomyocyte contractility through an ICAM-1-dependent mechanism.A mechanism for antibody-mediated outside-in activation of LFA-1.A novel leukocyte adhesion deficiency caused by expressed but nonfunctional beta2 integrins Mac-1 and LFA-1.Noninflammatory phagocytosis of monosodium urate monohydrate crystals by mouse macrophages. Implications for the control of joint inflammation in gout.CD147 monoclonal antibodies induce homotypic cell aggregation of monocytic cell line U937 via LFA-1/ICAM-1 pathway.Critical amino acids in the lymphocyte function-associated antigen-1 I domain mediate intercellular adhesion molecule 3 binding and immune functionThe I domain of integrin LFA-1 interacts with ICAM-1 domain 1 at residue Glu-34 but not Gln-73.Identification of amino acids in the CD11a I-domain important for binding of the leukocyte function-associated antigen-1 (LFA-1) to intercellular adhesion molecule-1 (ICAM-1)Inhibition of Binding of von Willebrand Factor to the Platelet Glycoprotein Ib-IX Complex, Heparin and Sulfatides by Polyanionic Compounds. The Mechanism of Modulation of the Adhesive Function of von Willebrand Factor.The Integrin α1 A-domain Is a Ligand Binding Site for Collagens and LamininThe A-Domain of Integrin alpha2 Binds Specifically to a Range of Collagens but is not a General Receptor for the Collagenous MotifAntibodies That Selectively Inhibit Leukocyte Function-associated Antigen 1 Binding to Intercellular Adhesion Molecule-3 Recognize a Unique Epitope within the CD11a I Domain
P2860
Q24313095-3C428313-9E1E-4177-826A-CC854AD63DCBQ24563636-FE9F9D3B-2EF9-40F9-9EA8-D46AB02AA185Q24646545-F6E36B6D-AF24-4107-BF34-44484408CFF1Q28295590-AA44D8B9-8A31-4F1F-8184-3E60553575E5Q31944613-E57DCA72-675E-4E08-A3A0-39ED85A0A89AQ32038862-E7C42091-DACF-47D0-90C3-311B787DAEBCQ33927511-CC9F45E8-B11C-4100-BC34-B0A4251AED84Q34184708-412A61B8-E604-4EF2-A4E6-221DD402EBBBQ34316037-59201CD2-E413-4D8B-B4A2-77E37C45F956Q34426260-E2375B59-F6EA-4B1A-A761-7B252133D038Q35001301-59A39E06-4A77-4033-864B-DAA9DA8579A9Q36255960-24063783-B003-41D7-89B5-90F5F3FA109DQ36273779-6EF192EA-746B-48E3-85EE-393832091F63Q36282882-614586F4-C5DF-4D18-8D4D-4266BF7218FBQ36371735-11261694-3C76-4D17-939A-6FC22D1CF8A7Q36642140-E6B655AF-BE00-4A71-B739-B12016C362D2Q40024433-71989345-E445-477E-8F84-509F4F314CB8Q40848368-8048773C-56AF-490C-9A68-CF760E04D172Q40861364-EA636D32-B1B4-40EC-B9CF-29B0553C25EAQ40955881-31B27BEA-A502-460E-A78F-616D007CEE8FQ41223173-9D2D1887-B662-4F23-9868-7B3D3B74D008Q42816968-F2303EF6-E702-4148-8A1C-4A7036265BE9Q46417075-E2AD1671-9D58-4D5A-B89A-C060DBF12FD2Q50764910-8ECFE12A-E83E-4F63-B6C8-CAFBFC3623A6Q58058124-0B596B4B-F28E-4D7A-91B7-5F5A0C90B29CQ58058138-D7CCFD25-F7C1-4D44-BD19-940FD0839374Q58620093-690D630B-0AD1-4959-BEF4-3BF18FCF6710
P2860
Involvement of the "I" domain of LFA-1 in selective binding to ligands ICAM-1 and ICAM-3.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Involvement of the "I" domain of LFA-1 in selective binding to ligands ICAM-1 and ICAM-3.
@en
Involvement of the "I" domain of LFA-1 in selective binding to ligands ICAM-1 and ICAM-3.
@nl
type
label
Involvement of the "I" domain of LFA-1 in selective binding to ligands ICAM-1 and ICAM-3.
@en
Involvement of the "I" domain of LFA-1 in selective binding to ligands ICAM-1 and ICAM-3.
@nl
prefLabel
Involvement of the "I" domain of LFA-1 in selective binding to ligands ICAM-1 and ICAM-3.
@en
Involvement of the "I" domain of LFA-1 in selective binding to ligands ICAM-1 and ICAM-3.
@nl
P2093
P2860
P356
P1476
Involvement of the "I" domain of LFA-1 in selective binding to ligands ICAM-1 and ICAM-3.
@en
P2093
P2860
P304
P356
10.1083/JCB.126.2.529
P407
P577
1994-07-01T00:00:00Z